small molecule

CYCLOSET

BROMOCRIPTINE MESYLATE

Loss of exclusivityApril 2032latest FDA-listed patent expiry

CompanyVeroscience →See this company's full patent-cliff portfolio

Drug detail

Brand name	CYCLOSET
Active ingredient	BROMOCRIPTINE MESYLATE
Strength	EQ 0.8MG BASE
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	May 2009
Marketing status	RX

Listed patents

Patent	Expires	Type
11666567	April 2032	use U-4018
10688094	April 2032	use U-2886
11000522	April 2032	use U-3122
8613947	April 2032	product
8431155	April 2032	product
9700555	April 2032	product
9993474	April 2032	use U-2389
9192576	April 2032	product
9522117	April 2032	product
8877708	June 2030	product
9352025	June 2030	use U-2116
9895422	June 2030	use U-2283
10688155	June 2030	use U-2934

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.